Business Description
Rekvina Laboratories Ltd
ISIN : INE092O01028
Compare
Compare
Traded in other countries / regions
526075.India IPO Date
1993-11-03Description
Rekvina Laboratories Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and marketing of pharmaceutical formulations. The company also has dispersible kid tablets for pediatric patients. The pharmaceutical products of the company include REKFA, an essential fatty acid in the capsule, and REKSEAL, the tissue adhesive.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.4 | |||||
| Equity-to-Asset | -0.25 | |||||
| Debt-to-Equity | -3.4 | |||||
| Debt-to-EBITDA | -3.18 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 36.6 | |||||
| 3-Year EPS without NRI Growth Rate | 36.8 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.86 | |||||
| Quick Ratio | 0.86 | |||||
| Cash Ratio | 0.86 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -3.23 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -33.68 | |||||
| ROIC % | -35.18 | |||||
| ROC (Joel Greenblatt) % | -53.47 | |||||
| ROCE % | -133.5 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -34.71 | |||||
| EV-to-EBITDA | -34.71 | |||||
| EV-to-FCF | -9035 | |||||
| Price-to-Projected-FCF | 225 | |||||
| Earnings Yield (Greenblatt) % | -2.88 | |||||
| FCF Yield % | -0.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Rekvina Laboratories Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | |||
| EPS (TTM) (₹) | -0.129 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (₹) | 0 | ||
| 20-Day SMA (₹) | 4.5 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (₹) | 4.5 - 4.5 | ||
| Shares Outstanding (Mil) | 6.03 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Rekvina Laboratories Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Rekvina Laboratories Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Rekvina Laboratories Ltd Frequently Asked Questions
What is Rekvina Laboratories Ltd(BOM:526075)'s stock price today?
The current price of BOM:526075 is ₹4.50. The 52 week high of BOM:526075 is ₹4.50 and 52 week low is ₹4.50.
When is next earnings date of Rekvina Laboratories Ltd(BOM:526075)?
The next earnings date of Rekvina Laboratories Ltd(BOM:526075) is .
Does Rekvina Laboratories Ltd(BOM:526075) pay dividends? If so, how much?
Rekvina Laboratories Ltd(BOM:526075) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers